Intraventricular recombinant alpha-interferon in subacute sclerosing panencephalitis

por Cianchetti, C., Fratta, A.L., Muntoni, F., Marrosu, M.G.
Publicado 1991

Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers

por Fenu, G., Fronza, M., Lorefice, L., Arru, M., Coghe, G., Frau, J., Marrosu, M. G., Cocco, E.
Publicado 2018

Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors?

por Frau, J., Cossu, D., Sardu, C., Mameli, G., Coghe, G., Lorefice, L., Fenu, G., Tranquilli, S., Sechi, L. A., Marrosu, M. G., Cocco, E.
Publicado 2016

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity

por Patti, F, Messina, S, Solaro, C, Amato, M P, Bergamaschi, R, Bonavita, S, Bruno Bossio, R, Brescia Morra, V, Costantino, G F, Cavalla, P, Centonze, D, Comi, G, Cottone, S, Danni, M, Francia, A, Gajofatto, A, Gasperini, C, Ghezzi, A, Iudice, A, Lus, G, Maniscalco, G T, Marrosu, M G, Matta, M, Mirabella, M, Montanari, E, Pozzilli, C, Rovaris, M, Sessa, E, Spitaleri, D, Trojano, M, Valentino, P, Zappia, M
Publicado 2016